These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 38657754)

  • 1. Fusobacterium nucleatum induces oxaliplatin resistance by inhibiting ferroptosis through E-cadherin/β-catenin/GPX4 axis in colorectal cancer.
    Li B; Wei Z; Wang Z; Xu F; Yang J; Lin B; Chen Y; Wenren H; Wu L; Guo X; Liu Y; Wei Y
    Free Radic Biol Med; 2024 Aug; 220():125-138. PubMed ID: 38657754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppressing the KIF20A/NUAK1/Nrf2/GPX4 signaling pathway induces ferroptosis and enhances the sensitivity of colorectal cancer to oxaliplatin.
    Yang C; Zhang Y; Lin S; Liu Y; Li W
    Aging (Albany NY); 2021 Mar; 13(10):13515-13534. PubMed ID: 33819186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SNHG4-mediated PTEN destabilization confers oxaliplatin resistance in colorectal cancer cells by inhibiting ferroptosis.
    Li SQ; Xu WT; Yin YX; Wei HT; Li KZ; Xie MZ; Lv F; Xie LY; Hu BL
    Apoptosis; 2024 Jun; 29(5-6):835-848. PubMed ID: 38573492
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Wu QL; Fang XT; Wan XX; Ding QY; Zhang YJ; Ji L; Lou YL; Li X
    World J Gastroenterol; 2024 Apr; 30(14):2018-2037. PubMed ID: 38681125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer.
    Nosho K; Sukawa Y; Adachi Y; Ito M; Mitsuhashi K; Kurihara H; Kanno S; Yamamoto I; Ishigami K; Igarashi H; Maruyama R; Imai K; Yamamoto H; Shinomura Y
    World J Gastroenterol; 2016 Jan; 22(2):557-66. PubMed ID: 26811607
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Hong J; Guo F; Lu SY; Shen C; Ma D; Zhang X; Xie Y; Yan T; Yu T; Sun T; Qian Y; Zhong M; Chen J; Peng Y; Wang C; Zhou X; Liu J; Liu Q; Ma X; Chen YX; Chen H; Fang JY
    Gut; 2021 Nov; 70(11):2123-2137. PubMed ID: 33318144
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Xu C; Fan L; Lin Y; Shen W; Qi Y; Zhang Y; Chen Z; Wang L; Long Y; Hou T; Si J; Chen S
    Gut Microbes; 2021; 13(1):1980347. PubMed ID: 34632963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21.
    Yang Y; Weng W; Peng J; Hong L; Yang L; Toiyama Y; Gao R; Liu M; Yin M; Pan C; Li H; Guo B; Zhu Q; Wei Q; Moyer MP; Wang P; Cai S; Goel A; Qin H; Ma Y
    Gastroenterology; 2017 Mar; 152(4):851-866.e24. PubMed ID: 27876571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FadA promotes DNA damage and progression of Fusobacterium nucleatum-induced colorectal cancer through up-regulation of chk2.
    Guo P; Tian Z; Kong X; Yang L; Shan X; Dong B; Ding X; Jing X; Jiang C; Jiang N; Yu Y
    J Exp Clin Cancer Res; 2020 Sep; 39(1):202. PubMed ID: 32993749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Replication Study:
    Repass J;
    Elife; 2018 Mar; 7():. PubMed ID: 29533182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association Between Fusobacterium nucleatum, Pathway Mutation, and Patient Prognosis in Colorectal Cancer.
    Lee DW; Han SW; Kang JK; Bae JM; Kim HP; Won JK; Jeong SY; Park KJ; Kang GH; Kim TY
    Ann Surg Oncol; 2018 Oct; 25(11):3389-3395. PubMed ID: 30062471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel antitumor mechanism of triptonide in colorectal cancer: inducing ferroptosis via the SLC7A11/GPX4 axis.
    Wang W; Zhao X; Zhou J; Li H
    Funct Integr Genomics; 2024 Jul; 24(4):126. PubMed ID: 39012393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin elicits antitumour effect by modulation of the gut microbiota and rescues Fusobacterium nucleatum-induced colorectal tumourigenesis.
    Huang X; Hong X; Wang J; Sun T; Yu T; Yu Y; Fang J; Xiong H
    EBioMedicine; 2020 Nov; 61():103037. PubMed ID: 33039709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delivery of short chain fatty acid butyrate to overcome Fusobacterium nucleatum-induced chemoresistance.
    Chen L; Zhao R; Kang Z; Cao Z; Liu N; Shen J; Wang C; Pan F; Zhou X; Liu Z; Yang Y; Chen Q
    J Control Release; 2023 Nov; 363():43-56. PubMed ID: 37734673
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Wang N; Zhang L; Leng XX; Xie YL; Kang ZR; Zhao LC; Song LH; Zhou CB; Fang JY
    Gut Microbes; 2024; 16(1):2333790. PubMed ID: 38533566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sec62 promotes stemness and chemoresistance of human colorectal cancer through activating Wnt/β-catenin pathway.
    Liu X; Su K; Sun X; Jiang Y; Wang L; Hu C; Zhang C; Lu M; Du X; Xing B
    J Exp Clin Cancer Res; 2021 Apr; 40(1):132. PubMed ID: 33858476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy.
    Yu T; Guo F; Yu Y; Sun T; Ma D; Han J; Qian Y; Kryczek I; Sun D; Nagarsheth N; Chen Y; Chen H; Hong J; Zou W; Fang JY
    Cell; 2017 Jul; 170(3):548-563.e16. PubMed ID: 28753429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knock down of BMSC-derived Wnt3a or its antagonist analogs attenuate colorectal carcinogenesis induced by chronic Fusobacterium nucleatum infection.
    Lin R; Han C; Ding Z; Shi H; He R; Liu J; Qian W; Zhang Q; Fu X; Deng X; Zhou S; Hou X
    Cancer Lett; 2020 Dec; 495():165-179. PubMed ID: 32920199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ANGPTL4-Mediated Promotion of Glycolysis Facilitates the Colonization of
    Zheng X; Liu R; Zhou C; Yu H; Luo W; Zhu J; Liu J; Zhang Z; Xie N; Peng X; Xu X; Cheng L; Yuan Q; Huang C; Zhou X
    Cancer Res; 2021 Dec; 81(24):6157-6170. PubMed ID: 34645607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin abrogates Fusobacterium nucleatum-induced chemoresistance in colorectal cancer by inhibiting miR-361-5p/sonic hedgehog signaling-regulated stemness.
    Hong XL; Yu TC; Huang XW; Wang JL; Sun TT; Yan TT; Zhou CB; Chen HM; Su WY; Du W; Xiong H
    Br J Cancer; 2023 Jan; 128(2):363-374. PubMed ID: 36396820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.